Navigation Links
Cell Therapeutics Announces Receipt of NASDAQ Panel Decision to Transfer to NASDAQ Capital Market
Date:1/6/2009

SEATTLE, Jan. 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it has received notification that the NASDAQ Listing Qualifications Panel has granted CTI's request to transfer the listing of its common stock from The NASDAQ Global Market to The NASDAQ Capital Market, which will be effective with the open of trading on Thursday, January 8, 2009. CTI's shares will continue to trade under the ticker symbol CTIC.

CTI's continued listing on The NASDAQ Capital Market is subject to CTI evidencing compliance with all applicable requirements for continued listing on The NASDAQ Capital Market, including the $35 million market value of listed securities requirement or its alternatives, as set forth in NASDAQ Marketplace Rule 4310(c)(3), by February 12, 2009. The Company expects to comply with all applicable requirements for continued listing on The NASDAQ Capital Market by February 12, 2009; however, there can be no assurance that it will be able to do so.

As disclosed on September 6 and October 10, 2008, CTI was previously notified by NASDAQ regarding its non-compliance with the $50 million market value of listed securities requirement for continued listing on The NASDAQ Global Market. In response, CTI appeared before the NASDAQ Listing Qualifications Panel at a hearing at which it requested the transfer of its listing to The NASDAQ Capital Market pursuant to its plan to evidence compliance with the $35 million market value of listed securities requirement for continued listing on that market.

The NASDAQ Capital Market is one of the three market tier designations for NASDAQ-listed stocks and operates in substantially the same manner as The NASDAQ Global Market. Securities listed on The NASDAQ Capital Market must satisfy all applicable qualification requirements for NASDAQ securities, and companies listed on The NASDAQ Capital Market must meet certai
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Horizon Therapeutics Announces Senior Management Appointments
2. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at the 27th Annual J.P. Morgan Healthcare Conference in San Francisco
3. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
4. Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
5. Nile Therapeutics Announces Positive Results from Phase 1b Safety and Pharmacodynamics Study of CD-NP in Patients with Heart Failure
6. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes
7. Intradigm Announces Issuance of Key Patent Related to Enhancing Efficacy and Potency of RNAi Therapeutics
8. Webcast Alert: Regulus Therapeutics, Alnylam Pharmaceuticals and Isis Pharmaceuticals Announce New Nature Publication on miR-21 Conference Call
9. FDA Accepts Cell Therapeutics Zevalin sBLA and Grants Priority Review
10. Cell Therapeutics, Inc. (CTI) Zevalin Joint Venture Conference Call to be Webcast with Slides
11. Cell Therapeutics, Inc. (CTI) to Discuss Zevalin Joint Venture with Spectrum Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... ROCKVILLE, Md. , March 3, 2015  Synthetic Biologics, ... serious infections and diseases, with a focus on protecting the ... Officer, is scheduled to present at the 27th Annual ROTH ... Laguna Niguel in Dana ... on Tuesday, March 10, 2015 at 1:00 p.m. (Pacific Time). ...
(Date:3/3/2015)...  PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: ... of three shareholder lawsuits filed in the fall of ... February 2, 2015, a securities lawsuit that was filed ... putative class of purchasers of the Company,s stock, Hampe ... Nev.), was voluntarily dismissed without prejudice.  Shortly thereafter, and ...
(Date:3/3/2015)... 2015  Phillip Sharp, Institute Professor at the Massachusetts Institute ... Biology and the Koch Institute for Integrative Cancer Research, will ... Day , May 14, at the Chemical Heritage Foundation. ... Medal since it was first awarded to Ralph ... Phil Sharp gave the scientific world a new view ...
(Date:3/2/2015)... COLUMBIA, Md. (PRWEB) March 02, 2015 ... poster sessions and present on LCMS and marijuana analysis ... takes place March 8 to 12 at the Ernest ... , Attendees can stop by booth 3121 to discuss ... how the company’s innovative, proven products help save time, ...
Breaking Biology Technology:Synthetic Biologics to Present at the 27th Annual ROTH Conference 2PDL BioPharma Announces Dismissal of Third and Final Shareholder Lawsuit 2Phillip Sharp to Receive 2015 Othmer Gold Medal 2Phillip Sharp to Receive 2015 Othmer Gold Medal 3Shimadzu Scientific Instruments Announces Product Launches, Presentations and Poster Sessions for Pittcon 2015 2Shimadzu Scientific Instruments Announces Product Launches, Presentations and Poster Sessions for Pittcon 2015 3
... in Quality by Design Initiative for Protein Therapeutics - ... Sciences, Inc. (Nasdaq: CALP ), a leading ... life sciences research, today launched the Staccato Protein Workstation ... therapeutics and biogenerics. , , With a ...
... Md., June 29 Micromet, Inc. (Nasdaq: ... for the treatment of cancer, inflammation and autoimmune diseases, ... 3000 Index as part of the annual reconstitution of ... , , "Investors recognize the Russell 3000 as ...
... ever involving patients with cutaneous T-cell lymphoma on schedule ... RADNOR, Pa., June 29 Yaupon Therapeutics, a privately ... enrollment for a pivotal Phase 2 clinical trial for ... (CTCL - stages 1-2a). The study, which is ...
Cached Biology Technology:Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis 2Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis 3Micromet Added to Russell 3000 Index 2Micromet Added to Russell 3000 Index 3Micromet Added to Russell 3000 Index 4Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cutaneous T-cell Lymphoma 2
(Date:2/24/2015)... NEW YORK , Feb. 24, 2015 This ... Thousands. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... America . Annual estimates and forecasts are provided for ... is provided for these markets. Market data and analytics are ...
(Date:2/23/2015)... Conn. , Feb. 23, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62114357 for DISTRIBUTED ... this patent, NXT-ID introduces a new groundbreaking payment method. ... the payment account may only be accessed if both ...
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
Breaking Biology News(10 mins):World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2
... The Institute for Translational Medicine and Therapeutics, 7th ... Personalization and the Science of Scale, to be ... direct relevance to translational science. ITMAT is part ... University of Pennsylvania. , Speakers will include those ...
... a humane option for the control of feral and ... issued by the International Society of Feline Medicine (ISFM) ... published by SAGE. According to the society, which ... Care, culling to control cat populations is also rarely ...
... screening shellfish for fungal toxins is important, say scientists. ... Society for Applied Microbiology (SfAM) journal, Letters in ... contamination by strains of Penicillium fungus, bivalve ... at much higher levels that are found in the ...
Cached Biology News:Lab-on-a-chip tech, brain mapping & microbiome highlighted at translational med meeting 2ISFM takes a stand on welfare of unowned cats 2